Applied Genetic Technologies reported $-13786000 in Operating Profit for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Applied Genetic Technologies AGTC:US $ -13.79M 0.7M
Avrobio Inc AVRO:US -31375000 4.49M
Biogen BIIB:US $ 794M 308.3M
Bluebird Bio BLUE:US $ -240.84M 9.63M
Celldex Therapeutics CLDX:US $ -13.44M 3.2M
Cti Biopharma CTIC:US $ -19.51M 2.44M
Gilead Sciences GILD:US $ 2246M 644M
Insmed INSM:US $ -106255000 22.42M
Intercept Pharmaceuticals ICPT:US $ 0.76M 30.11M
Regeneron Pharmaceuticals REGN:US $ 3347.2M 2234.5M
Rigel Pharmaceuticals RIGL:US $ -13.05M 54.8M
Ultragenyx Pharmaceutical RARE:US $ -82.78M 23.79M